NK VUE
LIVE

Serial Number

86300720

Owner

ATGen Co., Ltd.

Attorney

Deborah L. Corpus

First Use Date

Mar 31, 2015

Filing Date

Jun 4, 2014

Add to watchlist:

No watchlists yet
View on USPTO

NK VUE Trademark

Serial Number: 86300720 • Registration: 4993881

NK VUE is a trademark filed by ATGen Co., Ltd. on June 4, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ATGen Co., Ltd. (4 trademarks)

ATGen, Institut Pasteur Korea 2F
Gyeonggi-do 463-400 , KR

Entity Type: 99

NKMAX CO., LTD.

SNUH HIP 6F, 172 DOLMA-RO, BUNDANG-GU
SEONGNAM-SI, GYEONGGI-DO 13605 , KR

Entity Type: 99

Trademark Details

Filing Date

June 4, 2014

Registration Date

July 5, 2016

First Use Anywhere

March 31, 2015

First Use in Commerce

March 31, 2015

Published for Opposition

August 18, 2015

Goods & Services

diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use

NK cell activation testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical, research or medical laboratory use; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of (monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use

Filing History

TEAS SECTION 8 & 9 RECEIVED
Jun 4, 2026 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 29, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 29, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 29, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 29, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 29, 2025 COAR
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 5, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 4, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 4, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 4, 2023 APRE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 3, 2022 ASGN
TEAS SECTION 8 & 15 RECEIVED
Jul 19, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 5, 2021 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2016 TCCA
REGISTERED-PRINCIPAL REGISTER
Jul 5, 2016 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 2, 2016 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 1, 2016 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 17, 2016 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 12, 2016 AITU
USE AMENDMENT FILED
Apr 13, 2016 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 13, 2016 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 13, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 18, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 18, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 29, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 16, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 24, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 22, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 22, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 22, 2015 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 14, 2015 GNFN
FINAL REFUSAL E-MAILED
Apr 14, 2015 GNFR
FINAL REFUSAL WRITTEN
Apr 14, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2015 CRFA
ASSIGNED TO LIE
Mar 17, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2014 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2014 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2014 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2014 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Jun 18, 2014 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2014 NWOS
NEW APPLICATION ENTERED
Jun 7, 2014 NWAP